Volume 2.09 | Mar 11

Mammary Cell News 2.09, March 11, 2010.
In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  Events Subscribe  |  Unsubscribe

TOP STORY

Breast Cancer Drug Fulvestrant Appears More Effective in the Presence of CK8 and CK18
Women’s responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins. [Press release from Indiana University Bloomington discussing online prepublication in Cancer Biology & Therapy]

Watch Procedure Now  
Use EpiCult-B® to Culture and Characterize
Human Mammary Epithelial Progenitors

by STEMCELL Technologies
 
 
CLICK HERE TO LEARN MORE STEMCELL Technologies Inc
 



SCIENCE NEWS

Newly Published Data Shows Chronix Biomedical’s Serum DNA Assays Can Detect Early-Stage Breast Cancer
Chronix Biomedical announced publication of a study that supports the utility of its serum DNA blood tests for the early and accurate detection of breast cancer. [Press release from BusinessWire discussing online prepublication in Molecular Cancer Research]

MammoCultBreastCancer_645x110_v01



INDUSTRY NEWS

Canadian Budget Light on New Research Dollars
Relief was the order of the day for Canadian scientists recently as the federal government brought down its fiscal blueprint for 2010-11. [ScienceInsider]

In Annual Rite, Chinese Science Showered with Riches
At the opening session of the National People’s Congress, officials announced that the science and technology budget will rise 8% to 163.3 billion RMB ($24 billion) in 2010. [ScienceInsider]

Medifocus, Inc. Announces That It Has Received Approval to Initiate Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer from the Food and Drug Administration (FDA), Investigational Device Exemption (IDE) Application
Medifocus Inc. is pleased to announce that it has received from the Food and Drug Administration an Investigational Device Exemption approval to initiate a pivotal Phase III clinical trial upon obtaining institutional review board approval from the clinical sites, using the Company’s Microfocus APA 1000 System for the treatment of breast cancer. [BusinessWire]

Newly Published Data Shows Chronix Biomedical’s Serum DNA Assays Can Detect Early-Stage Breast Cancer
Chronix Biomedical announced the publication of a study that supports the utility of its serum DNA blood tests for the early and accurate detection of breast cancer. [Chronix Biomedical Press Report]

Life Technologies, TGen and US Oncology Partner on Groundbreaking Breast Cancer Sequencing Research
LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. [Life Technologies Press Release]


INDUSTRY NEWS

Canadian Budget Light on New Research Dollars
Relief was the order of the day for Canadian scientists recently as the federal government brought down its fiscal blueprint for 2010-11. [ScienceInsider]

In Annual Rite, Chinese Science Showered with Riches
At the opening session of the National People’s Congress, officials announced that the science and technology budget will rise 8% to 163.3 billion RMB ($24 billion) in 2010. [ScienceInsider]

Medifocus, Inc. Announces That It Has Received Approval to Initiate Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer from the Food and Drug Administration (FDA), Investigational Device Exemption (IDE) Application
Medifocus Inc. is pleased to announce that it has received from the Food and Drug Administration an Investigational Device Exemption approval to initiate a pivotal Phase III clinical trial upon obtaining institutional review board approval from the clinical sites, using the Company’s Microfocus APA 1000 System for the treatment of breast cancer. [BusinessWire]

Newly Published Data Shows Chronix Biomedical’s Serum DNA Assays Can Detect Early-Stage Breast Cancer
Chronix Biomedical announced the publication of a study that supports the utility of its serum DNA blood tests for the early and accurate detection of breast cancer. [Chronix Biomedical Press Report]

Life Technologies, TGen and US Oncology Partner on Groundbreaking Breast Cancer Sequencing Research
LifeTechnologies Corporation announced that it is collaborating with the Translational Genomics Research Institute and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. [Life Technologies Press Release]


POLICY NEWS

Request for Information (RFI): To Solicit Input for the National Institute of General Medical Sciences (NIGMS) Strategic Plan for Training and Career Development (NOT-GM-10-102) [National Institutes of Health, United States]

Correction to Required Budget Component for PAR-09-084: Enhancing Developmental Biology Research at Undergraduate Institutions Academic Research Enhancement Award (R15) (NOT-HD-10-007) [National Institutes of Health, United States]

Clarification of Budget Form for PAR-09-092 Academic-Community Partnership Conference Series (U13) (NOT-HD-10-009) [National Institutes of Health, United States]

Recovery Act Limited Competition: The NIH Director’s American Recovery & Reinvestment Act Funded Pathfinder Award to Promote Diversity in the Scientific Workforce (DP4) (RFA-OD-10-013) [National Institutes of Health, United States]

Minority Access to Research Careers Undergraduate Student Training in Academic Research (U-STAR) National Research Service Award (NRSA) Institutional Research Training Grant (T34) (PAR-10-119) [National Institutes of Health, United States]

Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01) (PAR-10-126) [National Cancer Institute, United States]

Collaborative Research for Molecular and Genomic Studies of Behavior in Animal Models (R01)
(PA-10-125)
[National Institute of General Medical Sciences, United States]

Workshops, Meetings & Conferences (Biologics) DIA/FDA CDER/CBER Computational Science Annual Meeting, Posted [Food and Drug Administration, United States]

Guidance for Industry: Characterization and Qualification of Cell Substrates and Other Biological Materials Used in the Production of Viral Vaccines for Infectious Disease Indications; Availability [Food and Drug Administration, United States]


EVENTS

7th European Breast Cancer Conference (EBCC)
March 24-27, 2010
Barcelona, Spain

34th Annual Symposium of the American Society of Breast Disease (ASBD)
April 16-17, 2010
New York City, United States

American Association for Cancer Research (AACR) 101st Annual Meeting 2010
April 17-21, 2010
Washington, DC, United States

BIT’s 3rd Annual World Cancer Congress 2010 – Breast Cancer Conference
April 25-27, 2010
Shanghai, China

IMPAKT Breast Cancer Conference
May 6-8, 2010
Brussels, Belgium

Breast Cancer Research 2010 Conference
May 18, 2010
London, United Kingdom

American Society of Clinical Oncology (ASCO) Annual Meeting 2010
June 4-8, 2010
Chicago, United States

Gordon Research Conference: Mammary Gland Biology
June 6-11, 2010
Lucca (Barga), Italy

12th Milan Breast Cancer Conference
June 16-18, 2010
Milan, Italy

The 21st Meeting of the European Association for Cancer Research (EACR)
June 26-29, 2010
Oslo, Norway


 

JOB OPPORTUNITIES

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.

Visit our events page  to stay up to date with the latest events in the cell, gene and immunotherapy community.


Have we missed an important article or publication in Mammary Cell News? Click here to submit!

 

Learn more about Mammary Cell News: Archives  |  Events  |  Subscribe  |  Contact Us